Peptides Similar to Klotho Peptides
Compare Klotho Peptides with related peptides and alternatives
📌TL;DR
- •3 similar peptides identified
- •Carnosine: Low-Moderate - Both target aging-related pathways but through different mechanisms. Carnosine is an anti-glycation dipeptide while klotho peptides target growth factor signaling.
- •Humanin: Moderate - Both are endogenous anti-aging peptides with neuroprotective properties. Both decline with age and have been linked to longevity.
Quick Comparison
| Peptide | Similarity | Key Differences |
|---|---|---|
| Klotho Peptides (current) | - | - |
| Carnosine | Low-Moderate - Both target aging-related pathways but through different mechanisms. Carnosine is an anti-glycation dipeptide while klotho peptides target growth factor signaling. | Carnosine is a widely available oral supplement with clinical trial data for glycemic control and cognition. Klotho peptides are preclinical research compounds targeting kidney fibrosis through TGF-beta and Wnt pathway inhibition. |
| Humanin | Moderate - Both are endogenous anti-aging peptides with neuroprotective properties. Both decline with age and have been linked to longevity. | Humanin is a mitochondria-derived peptide with direct cytoprotective effects. Klotho peptides are fragments of a transmembrane protein that modulate growth factor signaling. Different cellular origins and mechanisms. |
| GHK-Cu | Low-Moderate - Both are anti-aging peptides that address different aspects of the aging process. Both are derived from endogenous proteins. | GHK-Cu is a copper-binding tripeptide for skin and wound healing (topical/SubQ). Klotho peptides target organ fibrosis and growth factor signaling (IV). Entirely different mechanisms and applications. |
CarnosineLow-Moderate - Both target aging-related pathways but through different mechanisms. Carnosine is an anti-glycation dipeptide while klotho peptides target growth factor signaling.
Differences
Carnosine is a widely available oral supplement with clinical trial data for glycemic control and cognition. Klotho peptides are preclinical research compounds targeting kidney fibrosis through TGF-beta and Wnt pathway inhibition.
Advantages
Klotho peptides address upstream aging signaling pathways (TGF-beta, Wnt) with strong genetic evidence linking klotho to human longevity. Full klotho protein enhances cognition in nonhuman primates.
Disadvantages
Klotho peptides are entirely preclinical with no human data. Not available as supplements or drugs. Manufacturing and delivery challenges remain significant.
HumaninModerate - Both are endogenous anti-aging peptides with neuroprotective properties. Both decline with age and have been linked to longevity.
Differences
Humanin is a mitochondria-derived peptide with direct cytoprotective effects. Klotho peptides are fragments of a transmembrane protein that modulate growth factor signaling. Different cellular origins and mechanisms.
Advantages
Klotho has stronger genetic evidence (KL-VS variant) linking it to human cognition and longevity. Primate cognitive enhancement data published in Nature Aging.
Disadvantages
Klotho peptides are larger and more difficult to manufacture. Humanin analogs are further along in preclinical development for metabolic and neuroprotective applications.
GHK-CuLow-Moderate - Both are anti-aging peptides that address different aspects of the aging process. Both are derived from endogenous proteins.
Differences
GHK-Cu is a copper-binding tripeptide for skin and wound healing (topical/SubQ). Klotho peptides target organ fibrosis and growth factor signaling (IV). Entirely different mechanisms and applications.
Advantages
Klotho peptides target fundamental aging signaling pathways with published efficacy in kidney disease models and cognitive enhancement in primates.
Disadvantages
GHK-Cu is commercially available and has established clinical use in dermatology. Klotho peptides remain research-only compounds with no human safety data.
Peptides Related to Klotho Peptides#
Klotho peptides represent a unique approach to anti-aging therapeutics by targeting signaling pathways (TGF-beta, Wnt) that are modulated by the klotho longevity protein. Comparisons with other anti-aging peptides help contextualize their position in the field.
Carnosine#
Carnosine is the most accessible anti-aging peptide, available as an over-the-counter oral supplement.
Mechanistic comparison: Carnosine acts through direct biochemical mechanisms (anti-glycation, pH buffering, antioxidant activity), while klotho peptides modulate upstream growth factor signaling pathways. Carnosine addresses the consequences of aging (glycation damage, oxidative stress), while klotho peptides potentially address causes of aging (dysregulated growth factor signaling).
Evidence comparison: Carnosine has phase 2 RCT data in humans for glycemic control and cognitive function. Klotho peptides remain entirely preclinical. However, the klotho protein itself has strong human genetic evidence (KL-VS variant) and published primate cognitive data.
| Feature | Klotho Peptides | Carnosine |
|---|---|---|
| Type | Protein fragments (30 aa) | Dipeptide (2 aa) |
| Mechanism | TGF-beta/Wnt signaling inhibition | Anti-glycation, pH buffering |
| Administration | IV (preclinical) | Oral supplement |
| Human evidence | None (genetic epidemiology only) | Phase 2 RCTs |
| Availability | Research reagent only | OTC supplement |
| Cost | High (research grade) | Low |
Humanin#
Humanin is a 24-amino-acid peptide encoded by mitochondrial DNA, discovered as a neuroprotective factor.
Aging biology comparison: Both klotho and humanin are endogenous factors that decline with age and are associated with longevity. Both have neuroprotective properties. However, they arise from entirely different cellular compartments (klotho from the cell surface, humanin from mitochondria) and act through different mechanisms.
Therapeutic potential: Humanin and its synthetic analogs (HNG, [Gly14]-humanin) have been studied for metabolic, neuroprotective, and anti-apoptotic effects. Klotho has stronger human genetic validation (KL-VS variant) and the primate cognitive enhancement data.
GHK-Cu#
GHK-Cu is a copper-binding tripeptide with established use in dermatology.
Application comparison: GHK-Cu targets skin aging, wound healing, and hair growth through gene expression modulation. Klotho peptides target organ fibrosis and internal aging processes. They address completely different aspects of aging with no overlapping indications.
Epitalon#
Epitalon (Ala-Glu-Asp-Gly) is a tetrapeptide studied by the Khavinson group for telomerase activation and anti-aging effects.
Evidence comparison: Both epitalon and klotho peptides are in preclinical stages. Klotho peptides have higher-quality publications (Nature Communications, Nature Aging) and stronger mechanistic characterization. Epitalon's published evidence base consists primarily of studies from a single research group with limited independent replication.
Summary Comparison#
| Feature | Klotho Peptides | Carnosine | Humanin | GHK-Cu |
|---|---|---|---|---|
| Origin | Klotho protein fragments | Endogenous dipeptide | Mitochondrial peptide | Plasma tripeptide |
| Primary target | TGF-beta, Wnt | Glycation, ROS | Apoptosis, metabolism | Gene expression |
| Aging pathway | Growth factor signaling | Biochemical damage | Mitochondrial function | Tissue remodeling |
| Genetic evidence | Strong (KL-VS) | None | Limited | None |
| Primate data | Yes (full protein) | N/A | No | No |
| Human trials | None | Phase 2 RCTs | None | Limited |
| Availability | Research only | OTC supplement | Research only | Topical/research |
Related Reading#
Frequently Asked Questions About Klotho Peptides
Explore Further
Disclaimer: For educational purposes only. Not medical advice. Read full disclaimer